EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+1.88%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$6.75B
AUM Growth
+$6.75B
(+4.6%)
Cap. Flow
+$463M
Cap. Flow
% of AUM
6.86%
Top 10 Holdings %
Top 10 Hldgs %
24.03%
Holding
179
New
20
Increased
67
Reduced
21
Closed
18
Top Buys
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$65.6M |
| 2 |
Entegris
ENTG
|
$60.2M |
| 3 |
TSMC
TSM
|
$50.5M |
| 4 |
Cullinan Oncology
CGEM
|
$49M |
| 5 |
Zymeworks
ZYME
|
$44.1M |
Top Sells
| 1 |
Ecolab
ECL
|
$49.8M |
| 2 |
Wayfair
W
|
$49M |
| 3 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
$41.8M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$23.8M |
| 5 |
CrowdStrike
CRWD
|
$20.3M |
Sector Composition
| 1 | Healthcare | 40.17% |
| 2 | Technology | 26.2% |
| 3 | Industrials | 11.22% |
| 4 | Consumer Discretionary | 7.43% |
| 5 | Communication Services | 4.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ciena
CIEN
$13.4B
| $15.8M | 0.23% |
288,175
+21,175
| +8% | +$1.16M |
|
102
Lamb Weston
LW
$7.88B
| $15.7M | 0.23% |
203,000
| – | – |
|
103
Agilent Technologies
A
$35.5B
| $15.7M | 0.23% |
123,700
+31,200
| +34% | +$3.97M |
|
104
First Horizon
FHN
$11.4B
| $14.7M | 0.22% |
868,800
+175,100
| +25% | +$2.96M |
|
105
Pharvaris
PHVS
$1.41B
| $14M | 0.21% |
+500,000
| New | +$14M |
|
|
APTO
106
DELISTED
Aptose Biosciences, Inc.
APTO
| $13.7M | 0.2% |
2,299,000
| – | – |
|
107
Shoals Technologies Group
SHLS
$1.13B
| $13.7M | 0.2% |
+392,556
| New | +$13.7M |
|
108
Prologis
PLD
$103B
| $13M | 0.19% |
123,044
+31,944
| +35% | +$3.39M |
|
109
Steris
STE
$23.9B
| $12.9M | 0.19% |
67,600
+35,950
| +114% | +$6.85M |
|
|
BCYC
110
Bicycle Therapeutics
BCYC
$492M
| $12.3M | 0.18% |
+411,838
| New | +$12.3M |
|
111
Synovus
SNV
$7.14B
| $12.2M | 0.18% |
+265,900
| New | +$12.2M |
|
112
Design Therapeutics
DSGN
$339M
| $12M | 0.18% |
+400,000
| New | +$12M |
|
113
KLA
KLAC
$111B
| $11.8M | 0.18% |
35,798
+10,300
| +40% | +$3.4M |
|
114
Pentair
PNR
$17.5B
| $11.1M | 0.17% |
178,700
+78,600
| +79% | +$4.9M |
|
115
Bolt Biotherapeutics
BOLT
$9.29M
| $10.6M | 0.16% |
+322,944
| New | +$10.6M |
|
116
Oric Pharmaceuticals
ORIC
$1.03B
| $10.5M | 0.16% |
430,000
| – | – |
|
|
SGFY
117
DELISTED
Signify Health, Inc.
SGFY
| $10.5M | 0.16% |
+357,360
| New | +$10.5M |
|
|
CHMA
118
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $9.39M | 0.14% |
3,000,326
| – | – |
|
|
SBNY
119
DELISTED
Signature Bank
SBNY
| $8.41M | 0.12% |
37,200
+11,300
| +44% | +$2.55M |
|
120
IDEX
IEX
$12.1B
| $7.89M | 0.12% |
37,700
+20,176
| +115% | +$4.22M |
|
121
Synopsys
SNPS
$110B
| $6.93M | 0.1% |
27,957
+10,648
| +62% | +$2.64M |
|
122
ALX Oncology
ALXO
$54.6M
| $6.64M | 0.1% |
+90,000
| New | +$6.64M |
|
123
VF Corp
VFC
$5.79B
| $6.52M | 0.1% |
81,600
+58,000
| +246% | +$4.64M |
|
124
American Water Works
AWK
$27.5B
| $6.46M | 0.1% |
43,100
+14,200
| +49% | +$2.13M |
|
125
Fennec Pharmaceuticals
FENC
$247M
| $6.46M | 0.1% |
1,040,000
-80,000
| -7% | -$497K |
|